HORIZON-HLTH-2024-DISEASE-08-20
HORIZON-HLTH-2024-DISEASE-08-20
Programme: Horizon Europe
7 projects · €54,385,490 total EU contribution (project-level) · 58 participating organizations · 22 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€54,385,490
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (14)
- Italy (8)
- IN (5)
- Netherlands (4)
- NO (3)
- SE (3)
- US (3)
- AU (2)
- CH (2)
- France (2)
- AT (1)
- BE (1)
- CZ (1)
- DK (1)
- Spain (1)
- FI (1)
- GT (1)
- PL (1)
- PT (1)
- RO (1)
- SI (1)
- UK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KI4 projects · SE
- IP3 projects · FR
- UMR3 projects · DE
- BNI2 projects · DE
- EPFL2 projects · CH
- HZI2 projects · DE
- HELSINGIN YLIOPISTO2 projects · FI
- LUNDS UNIVERSITET2 projects · SE
- UKHD2 projects · DE
- UNIVERSITY OF OSLO2 projects · NO
- Artemis Hospital1 projects · IN
- CIC BIOGUNE1 projects · ES
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Advancing Pandemic Preparedness: Innovative Multidisciplinary Strategies for COMBATing Severe Dengue COMBAT · 101191315 | HORIZON | €7,999,993 | €450,000 | Details |
Receptor-Focused Interventions Against Orthoflavivirus Neuroinvasion and Entry REFINE · 101191791 | HORIZON | €7,705,322 | €2,886,988 | Details |
Comparative signature of Marburg virus cell activation as a blueprint for the identification of antiviral targets against newly emerging viruses COMBINE · 101191739 | HORIZON | €7,285,044 | €830,580 | Details |
Identification of novel viral entry factors and development of antiviral approaches DEFENDER · 101191666 | HORIZON | €7,949,326 | €1,303,431 | Details |
Counter-acting the pandemic potential of flaviviruses: addressing virus-host interactions and defense strategies to design new therapeutics against WNV and DENV InFlaMe · 101191725 | HORIZON | €7,995,922 | €859,300 | Details |
Targeting ER Import And Activation Of Viral Glycoproteins: Towards Broad-Spectrum Antivirals VIGILANT · 101191811 | HORIZON | €7,471,718 | €590,000 | Details |
MOLECULAR STRATEGIES AGAINST VIRAL ENTRY AND GLYCAN SHIELDING SHIELD · 101191794 | HORIZON | €7,978,166 | €682,525 | Details |